The global migraine drugs market garnered $1.71 billion in 2017 and is expected to reach $2.19 billion by 2025, thereby growing at a significant CAGR of 3.1% during the forecast period, 2018 to 2025.
Download Sample Report: https://www.alliedmarketresearch.com/request-sample/2811
The study is an in-depth analysis of the global migraine drugs market. It enables the interested market players and investors to understand the entire market with the help of critical industry insights. It offers an overview of the drivers, restraints, and opportunities impacting the industry. It discusses the market size and share, segmentation, and technology trends that prevail in the industry. Information about the key players operating in the market are also discussed.
The report elaborately analyzes the drivers, restraints, and opportunities of the global migraine drugs market. Factors such as an increase in prevalence of migraine, growth in female population, and rise in awareness of migraine treatment & prevention among patients are the factors that drive the growth of the market. However, side effects of migraine drugs act as major restraints for the growth of the industry. On the other hand, emerging migraine therapies and growth opportunities in the emerging economies create lucrative opportunities for the market.
The report emphasizes on the various segments of the global migraine drugs market. The market is segmented into type, route of administration, distribution channel, and geography. Based on type, the market is divided into abortive medicine and preventive medicine. The abortive medicine segment is again divided into triptans (serotonin receptor agonists), ergotamine derivative, and others. The preventive medicine segment is divided into anticonvulsant, antidepressant, beta blocker, and others. The route of administration segment is divided into oral, injection, and others. The distribution channel segment is bifurcated into hospital-based pharmacies, retail pharmacies and online pharmacies. Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. The market analysis in North America includes the U.S., Canada, and Mexico. The market analysis in Europe covers UK, Germany, France, Italy, Spain, and the rest of Europe. The study in the Asia-Pacific region covers China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific. In LAMEA, the market study covers Brazil, Saudi Arabia, South Africa, and the rest of LAMEA.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2811
The key players in the global migraine drugs market are expanding the scope of their business operations in the developing countries by including innovative products in their product portfolios. The report includes a detailed competitive analysis of the major market players, such as Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Impax Laboratories, Johnson & Johnson, Merck & Co., and Pfizer Inc.
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060